Protagenic Therapeutics Files 8-K on Agreements and Equity Sales
Ticker: PTIXW · Form: 8-K · Filed: May 20, 2025 · CIK: 1022899
| Field | Detail |
|---|---|
| Company | Protagenic Therapeutics, Inc.\New (PTIXW) |
| Form Type | 8-K |
| Filed Date | May 20, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, equity-sale, filing
Related Tickers: PTIX
TL;DR
PTIX filed an 8-K today covering material agreements and equity sales. Watch for details.
AI Summary
Protagenic Therapeutics, Inc. filed an 8-K on May 20, 2025, reporting on the entry into a material definitive agreement and unregistered sales of equity securities. The filing also includes financial statements and exhibits. The company was formerly known as Atrinsic, Inc., New Motion, Inc., and MPLC, Inc.
Why It Matters
This 8-K filing indicates significant corporate actions, including definitive agreements and equity transactions, which could impact the company's financial structure and future operations.
Risk Assessment
Risk Level: medium — The filing involves material definitive agreements and unregistered sales of equity, which can introduce financial and operational risks.
Key Players & Entities
- Protagenic Therapeutics, Inc. (company) — Filer
- Atrinsic, Inc. (company) — Former Company Name
- New Motion, Inc. (company) — Former Company Name
- MPLC, Inc. (company) — Former Company Name
- May 20, 2025 (date) — Date of Report
FAQ
What type of material definitive agreement did Protagenic Therapeutics enter into?
The filing indicates the entry into a material definitive agreement, but the specific details of the agreement are not provided in this excerpt.
What was the nature of the unregistered sales of equity securities?
The filing reports unregistered sales of equity securities, but the specifics of these sales, including the amount and terms, are not detailed in this excerpt.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on May 20, 2025.
What is Protagenic Therapeutics, Inc.'s standard industrial classification?
Protagenic Therapeutics, Inc.'s standard industrial classification is Pharmaceutical Preparations [2834].
What are the previous names of Protagenic Therapeutics, Inc.?
Protagenic Therapeutics, Inc. was formerly known as Atrinsic, Inc., New Motion, Inc., and MPLC, Inc.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 20, 2025 regarding Protagenic Therapeutics, Inc.\new (PTIXW).